BioSpace News Archive

Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces its full year results for the twelve months ended 30 June 2022.

Quotient Limited, a commercial-stage diagnostics company, announced that it will effect a one-for-40 reverse stock split of its ordinary shares, nil par value that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market.

Biofrontera Inc. announced today it has entered into private exchange agreements with certain holders of options to acquire ordinary shares of Biofrontera AG.

Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, will present its diagnostic lab solutions at the upcoming annual meeting of the Association for Molecular Pathology (AMP), taking place November 1-5 in Phoenix, Ariz.

Senhwa Biosciences, Inc. announced today that their first patient has been successfully dosed, in a phase I clinical study evaluating the combined treatment with Senhwa’s Pidnarulex.

Coeptis Therapeutics, Inc., a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced the completion of its business combination with Bull Horn Holdings Corp., a special purpose acquisition company.

Nuvalent, Inc. today announced that it has commenced an underwritten public offering of $200.0 million of its shares of Class A common stock.

Ardelyx, Inc. today announced that its collaboration partner in Japan, Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin), has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis.

AcelRx Pharmaceuticals, Inc. today announced that an abstract, entitled, “Experience in Complex Outpatient Plastic Surgery Procedures Using Sufentanil Sublingual Tablets” was presented on Friday, October 28th by Jeffrey DeWeese, M.D., FACS, at Plastic Surgery The Meeting 2022, held October 27-30, in Boston, MA.

Noul Co., Ltd., a Biotech Company, announced that it will participate in the 2022 American Society of Tropical Medicine and Hygiene annual meeting held from October 30 to November 3 in Seattle, USA.